NovAliX

NovAliX

Fabrication de produits pharmaceutiques

Strasbourg, Grand Est 14 192 abonnés

NovAliX is a preclinical drug discovery-focused CRO

À propos

NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com

Site web
http://www.novalix.com
Secteur
Fabrication de produits pharmaceutiques
Taille de l’entreprise
201-500 employés
Siège social
Strasbourg, Grand Est
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2002
Domaines
Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry et Chemical process research

Lieux

Employés chez NovAliX

Nouvelles

Pages similaires

Parcourir les offres d’emploi

Financement

NovAliX 1 round en tout

Dernier round

Série inconnue

2 430 908,00 $US

Voir plus d’informations sur Crunchbase